5-hydroxy-7,8-dimethoxyflavone has been researched along with baicalin in 1 studies
| Studies (5-hydroxy-7,8-dimethoxyflavone) | Trials (5-hydroxy-7,8-dimethoxyflavone) | Recent Studies (post-2010) (5-hydroxy-7,8-dimethoxyflavone) | Studies (baicalin) | Trials (baicalin) | Recent Studies (post-2010) (baicalin) |
|---|---|---|---|---|---|
| 11 | 0 | 6 | 1,434 | 15 | 994 |
| Protein | Taxonomy | 5-hydroxy-7,8-dimethoxyflavone (IC50) | baicalin (IC50) |
|---|---|---|---|
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 3.19 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 6.41 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.4104 | |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | 3.61 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ouyang, L; Wang, J; Wang, Y; Zhang, J; Zhang, L | 1 |
1 review(s) available for 5-hydroxy-7,8-dimethoxyflavone and baicalin
| Article | Year |
|---|---|
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential.
Topics: Antineoplastic Agents; Cell Cycle Proteins; Humans; Neoplasms; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins | 2022 |